The diagnostic value of the circadian rhythm gene KLF10 in anxiety‐depressive disorders and its neuroimmune regulatory mechanisms
Animal Models and Experimental Medicine · 2026
DOI: 10.1002/ame2.70276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2026. Verfasst von Anlan Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Kruppel-Like Transcription Factors, Circadian Rhythm, Anxiety Disorders, Depressive Disorder. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Graduate Research and Innovation Projects of Jiangsu Province, Science and Technology Program of Suzhou, Natural Science Foundation of Nanjing University of traditional Chinese medicine.
Abstract (Originalsprache)
Background
Anxiety‐depressive disorder (ADD) is one of the important subtypes of depression, which has been shown to be closely related to neuroimmune abnormalities. Currently, specific biomarkers have not been identified as diagnostic, differential, and therapeutic targets. This study aimed to explore the molecular mechanisms and diagnostic biomarkers of ADD and elucidate its association with neuroinflammation.
Methods
Differentially expressed circadian rhythm‐related genes were screened. Key genes were identified by machine learning. An ADD rat model was established using chronic restraint stress combined with corticosterone administration. Using AAV virus tools for KLF‐10 overexpression and knockout (KLF10‐OE and shKLF10), depression‐like and anxiety‐like behaviors were evaluated through behavioral experiments, pathological changes in the hippocampus and amygdala were observed by Nissl staining, cytokine levels were detected by ELISA, molecular co‐localization was performed by RNAscope ISH and immunofluorescence, and molecular expression of NF‐κB/NLRP3 pathway was detected by Western blot and qRT PCR.
Results
Nine circadian rhythm‐related genes showed significant differential expression, with KLF10 identified as a diagnostic biomarker. KLF10 overexpression ameliorated depressive‐like and anxiety‐like behaviors, and reduced pro‐inflammatory factors (IL‐1β, TNF‐α) and increased anti‐inflammatory factors (IL‐10, TGF‐β) in both brain and serum, the treatment can be blocked by PMA. KLF10 suppressed IκB‐α phosphorylation‐mediated NF‐κB nuclear translocation and inhibited downstream molecules.
Conclusion
KLF10 mitigates hippocampal‐amygdala neuroinflammation by downregulating the NF‐κB/NLRP3 pathway, thereby alleviating a ADD symptoms, and represents a potential diagnostic biomarker and therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou University of Chinese Medicine, Guangzhou, China.
- Nanjing University of Chinese Medicine, Nanjing, China.
- Taicang Hospital Affiliated to Nanjing University of Chinese Medicine (Taicang Traditional Chinese Medicine Hospital), Suzhou, China.
ORCID-Profile: Dan Xu
Förderung
- Graduate Research and Innovation Projects of Jiangsu Province
- Science and Technology Program of Suzhou
- Natural Science Foundation of Nanjing University of traditional Chinese medicine
Zitieren
APA
Liu, A., Guo, W., Li, J., Zhang, T., & Xu, D. (2026). The diagnostic value of the circadian rhythm gene KLF10 in anxiety‐depressive disorders and its neuroimmune regulatory mechanisms. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70276
Vancouver
Liu A, Guo W, Li J, Zhang T, Xu D. The diagnostic value of the circadian rhythm gene KLF10 in anxiety‐depressive disorders and its neuroimmune regulatory mechanisms. Animal Models and Experimental Medicine. 2026. doi:10.1002/ame2.70276
BibTeX
@article{Liu2026,
author = {Liu, Anlan and Guo, Weifeng and Li, Jianxiang and Zhang, Tiange and Xu, Dan},
title = {The diagnostic value of the circadian rhythm gene KLF10 in anxiety‐depressive disorders and its neuroimmune regulatory mechanisms},
journal = {Animal Models and Experimental Medicine},
year = {2026},
doi = {10.1002/ame2.70276}
}
EUVIMED